SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation30-09-2024
30-09-2024
UBS initiates coverage on 6 pharma stocks. Sun Pharma, Cipla among top buys
Global brokerage firm UBS has initiated coverage on several pharma stocks, highlighting potential upsides and challenges within the sector. The report points to weakening trends in both India and the US, with underappreciated growth slowdowns in these markets. UBS has provided a mixed outlook, issuing both 'Buy' and 'Sell' ratings on a range of pharmaceutical stocks.Here is a list of 6 pharma stocks on which UBS initiated coverage:28-09-2024
Sun Pharma gains 3%; hits new high on UBS 'Buy' rating, sees more upside
UBS has a target price of Rs 2,450 on Sun Pharma and expects it to record the highest growth in the near-term and the medium-term via a ramp-up of the specialty drug pipelline.27-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma presents new clinical efficacy and safety data at 2024 EADV congress.26-09-2024
Sun Pharma, Glemnark, Alkem Labs Under Scrutiny As CDSCO Flags 53 Drugs For Quality Failures
Sun Pharma's Pantocid tablets, used for acid reflux, the Pulmosil injection for high blood pressure, and Ursocol 300 tablets, were all declared adulterated in August.25-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate.25-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window
Intimation regarding Closure of Trading Window.24-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Response To Your Email On Increase In Volume
Response to BSE on increase in volume23-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Clarification sought from Sun Pharmaceutical Industries Ltd
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on September 23, 2024, with reference to Movement in Volume.The reply is awaited.23-09-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Certificate18-09-2024